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and Mohammed Benghezal**
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Gpi7 was isolated by screening for mutants defective
in the surface expression of glycosylphosphatidylinosi-
tol (GPI) proteins. Gpi7 mutants are deficient in
YJL062w, herein named GPI7. GPI7 is not essential, but
its deletion renders cells hypersensitive to Calcofluor
White, indicating cell wall fragility. Several aspects of
GPI biosynthesis are disturbed in Dgpi7. The extent of
anchor remodeling, i.e. replacement of the primary lipid
moiety of GPI anchors by ceramide, is significantly re-
duced, and the transport of GPI proteins to the Golgi is
delayed. Gpi7p is a highly glycosylated integral mem-
brane protein with 9–11 predicted transmembrane do-
mains in the C-terminal part and a large, hydrophilic
N-terminal ectodomain. The bulk of Gpi7p is located at
the plasma membrane, but a small amount is found in
the endoplasmic reticulum. GPI7 has homologues in
Saccharomyces cerevisiae, Caenorhabditis elegans, and
man, but the precise biochemical function of this pro-
tein family is unknown. Based on the analysis of M4, an
abnormal GPI lipid accumulating in gpi7, we propose
that Gpi7p adds a side chain onto the GPI core struc-
ture. Indeed, when compared with complete GPI lipids,
M4 lacks a previously unrecognized phosphodiester-
linked side chain, possibly an ethanolamine phosphate.
Gpi7p contains significant homology with phosphodies-
terases suggesting that Gpi7p itself is the transferase
adding a side chain to the a1,6-linked mannose of the
GPI core structure.
Glycosylphosphatidylinositol (GPI)1-anchored proteins rep-
resent a subclass of surface proteins found in virtually all
eukaryotic organisms (1). The genome of Saccharomyces cerevi-
siae contains more than 70 open reading frames (ORFs) encod-
ing for proteins that, as judged from the deduced primary
sequence, can be predicted to be modified by the attachment of
a GPI anchor (2, 3). In about 25 of them, the presence of an
anchor has been confirmed biochemically. A majority of them
lose part of the anchor and become covalently attached to the
b1,6-glucans of the cell wall (4–6). A minority of GPI proteins
retain the GPI anchor in an intact form and stay at the plasma
membrane (PM).
For the biosynthesis of GPI anchors, phosphatidylinositol
(PI) is modified by the stepwise addition of sugars and etha-
nolamine phosphate (EtN-P), thus forming a complete precur-
sor lipid (CP) which subsequently is transferred en bloc by a
transamidase onto newly synthesized proteins in the ER (7, 8).
The identification of genes involved in the biosynthesis of the
CP and its subsequent attachment to proteins has been possi-
ble through the complementation of mammalian and yeast
gpi2 mutants, i.e. mutants being deficient in GPI anchoring of
membrane proteins (7, 9–20). In our laboratory, a series of
recessive gpi2 mutants (gpi4 to gpi10) has been obtained by
screening for yeast mutants that are unable to display the
GPI-anchored a-agglutinin (Sag1p) at the outer surface of the
cell wall, although the synthesis and secretion of soluble pro-
teins is normal (21, 22).
Here we report on the characterization of gpi7. Four inde-
pendent gpi7 mutants accumulated M4, an abnormal GPI in-
termediate that is less hydrophilic than CP2, the precursor
accumulating when the transfer of GPIs to proteins is inter-
rupted (18, 19, 21, 23). Our preliminary characterization of M4
had shown that deacylation by NH3 followed by HF treatment,
used to hydrolyze selectively the phosphodiester bonds (Fig. 1),
yielded the same Man4-GlcN-inositol fragment as CP2, and we
speculated that gpi7 mutants may be unable to add the EtN-P
onto Man3 (Fig. 1) (21). Here we show that this speculation was
wrong, that CP2 differs from M4 with regard to a previously
unrecognized side chain attached to Man2 (Fig. 1), and that
GPI7 is required for the attachment of this side chain.
EXPERIMENTAL PROCEDURES
Strains, Growth Conditions, and Materials—S. cerevisiae strains
were FBY11 (MATa ade2-1 ura3-1 leu2-3,112 trp1-1 his3-11,15 gpi8-1),
FBY15 (MATa ade2-1 ura3-1 leu2-3,112 trp1-1 his3-11,15 gpi7-1),
W303-1B (MATa ade2-1 can1-100 ura3-1 leu2-3, 112 trp1-1 his3-11,15),
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X2180-1A (MATa lys2), FBY122 (MATa ade2-1 ura3-1 leu2-3,112
trp1-1 his3-11,15 gpi8-1 gpi7-1), FBY182 (MATa ade2-1 ura3-1 leu2-
3,112 his3-11,15 gpi7::KanMX4), HMSF176 (MATa sec18-1), FBY49
(MATa sec18-1 gpi7::KanMX4), C4 (MATa ura3-52 leu2-3,112 pmi40),
HMSF331 (MATa sec53-6), LB2134-3B (MATa mnn9), and YNS3-7A
(MATa ura3 his2 mnn1 och1::LEU2). Diploid strains were FBY118
(MATa/a ade2-1/ade2-1 ura3-1/ura3-1 leu2-3, 112/leu2-3,112 TRP1/
trp1-1 his3-11,15/his3-11,15 LYS/lys2), FBY40 (MATa/a ade2-1/
ade2-1 ura3-1/ura3-1 leu2-3,112/leu2-3,112 TRP1/trp1-1 his3-11,15/
his3-11,15 LYS/lys2 GPI7/gpi7-1), and FBY43 (MATa/a ade2-1/
ade2-1 ura3-1/ura3-1 leu2-3,112/leu2-3,112 TRP1/trp1-1 his3-11,15/
his3-11,15 LYS/lys2 gpi7::KanMX4/gpi7::KanMX4). Maintenance and
growth conditions have been described (19). The absorbance of dilute
cell suspensions was measured in a 1-cm cuvette at 600 nm, and one
A600 unit of cells corresponds to 1–2 3 10
7 cells depending on the strain.
Escherichia coli strains were HB-101, XL1 blue, and M15 [pREP4]
(Qiagen).
Materials were obtained from the sources described recently (22).
Cysteamine was from Sigma; [3H]dihydrosphingosine was synthesized
as described (24); myriocin was a kind gift of Dr. N. Rao Movva (No-
vartis, Basel, Switzerland); antibodies to Och1p, alkaline phosphatase,
Kex2p, and Wbp1p were kindly donated by Dr. Y. Jigami, National
Institute of Bioscience and Human Technology, Ibaraki 305, Japan; Dr.
S. Emr, Howard Hughes Medical Institute, University of California,
San Diego; Dr. R. Fuller, University of Michigan Medical Center, Ann
Arbor, MI; and Dr. M. Aebi, Mikrobiologisches Institut, ETH Zu¨rich,
Switzerland, respectively.
Cloning, Partial Sequencing, and Disruption of GPI7—The GPI7
gene was cloned by complementation of the ts growth phenotype of the
gpi7-1/gpi8-1 double mutant as described (19). The three plasmids
complementing gpi7-1 contained a 4.3-kb common DNA restriction
fragment that was partially sequenced by the dideoxy sequencing
method (25). The complementing insert SphI/SspI of 3.6 kb was cloned
into the SphI/SmaI-digested YEp352 multicopy vector (26) or YCplac33
single copy vector (27) to generate pBF41 (Fig. 3C) and pBF43,
respectively.
One step disruption of GPI7 was done as described (28). Briefly, the
1.5-kb long KanMX4 module was PCR-amplified by using pFA6a-
KanMX4 as template and the following two adapter primers: GPI7-
forwards (59-CTTCACCAAGTTAGCAAGATGAACTTGAAGCAGTTC-
ACGTGCCtcgatgaattcgagctc-39) with 17 nucleotides (nt) of homology to
the pFA6a-KanMX4 multiple cloning site (in lowercase) and 43 nt of
homology to GPI7 (in uppercase) starting 18 nt upstream of the start
codon (bold); GPI7-backwards (59-ATCAAGAGCGCAAAGGAGGGCC-
AATTCAGGTAACCAGCCATTCAcgtacgctgcaggtcgac-39) with 18 nt of
homology to the pFA6a-KanMX4 multiple cloning site (lowercase) and
44 nt of homology to the ORF of GPI7 in the region immediately up-
stream of the stop codon. This PCR DNA fragment was used to tra-
nsform the diploid strain FBY118, homozygous for GPI7, and FBY40, a
heterozygous gpi7-1/GPI7 strain. The correct targeting of the PCR-
made KanMX4 module into the GPI7 locus in geneticin-resistant clones
was verified by PCR with whole yeast cells using primers GPI7-plus
(59-GTTCATCTACCACGCAC-39) starting 36 nt upstream of the ATG,
GPI7-minus (59-GACCCAAGTAATGCAGG-39) starting 631 base pairs
downstream of the ATG and the K2 primer of the KanMX4 module
(59-GTATTGATGTTGGACG-39).
Purification of Recombinant His-tagged Gpi7p and Antibody Produc-
tion—Plasmid pBF41 (Fig. 3C) was digested with BstYI and EcoRV to
generate a 633-base pair fragment of GPI7. This fragment was inserted
into the multiple cloning site of the bacterial expression vector pQE-30
(Qiagen) digested with BamHI/SmaI thus generating the plasmid
pBF402. This plasmid was used to transform the E. coli strain
M15[pREP4]. Expression of the recombinant protein was induced with
isopropyl-1-thio-b-D-galactopyranoside and purified on a nickel-nitrilo-
triacetic acid-agarose column (Qiagen) under denaturing conditions
according to the manufacturer’s instructions. A polyclonal antiserum
was raised against this Gpi7p fragment by repeated intramuscular
injections of 100 mg of recombinant protein into a rabbit. Ten mg of the
recombinant protein were coupled to CNBr-activated Sepharose 4B
(Amersham Pharmacia Biotech) according to the manufacturer’s in-
structions, and antiserum was affinity purified as described (29).
Membrane Association, Protease Sensitivity, and Cellular Localiza-
tion of Gpi7p—The nature of the association of Gpi7p with the mem-
brane was determined following a previously described protocol (30)
except that the EDTA concentration in buffer G was increased from 2 to
20 mM. Gpi7p protease sensitivity was examined by proteinase K di-
gestion of microsomes essentially as described (31). Briefly, 100 A600 of
washed W303 cells were resuspended in 1 ml of lysis buffer (20 mM
HEPES, pH 7.5, 500 mM sucrose, 3 mM magnesium acetate, 20 mM
EDTA, 1 mM dithiothreitol) and were lysed by agitation with glass
beads at 4 °C. The homogenate was centrifuged for 5 min at 600 3 g to
remove unbroken cells, and the supernatant was centrifuged for 15 min
at 13,000 3 g. The membrane pellet was resuspended in 240 ml of the
same lysis buffer and split into 6 aliquots of equal size. Aliquots of
microsomes were incubated for 20 min on ice with or without 0.5%
Triton X-100 and proteinase K. Digestions were stopped by addition of
phenylmethylsulfonyl fluoride (final concentration 4 mM, added from a
200 mM stock in ethanol) and kept on ice for an additional 10 min before
being boiled in sample buffer (32). The subcellular localization of Gpi7p
was determined essentially as described (33). Briefly, 500 A600 units of
mid-log phase W303-1B cells were broken by agitation with glass beads
in 200 mM sorbitol, 25 mM PIPES, pH 6.8, 50 mM KCl, 5 mM NaCl, 10
mM EDTA, 10 mM NaN3/NaF, 1 mM phenylmethylsulfonyl fluoride,
leupeptin, pepstatin, and antipain, each at 30 mg/ml). After removal of
the unbroken cells the homogenate was centrifuged for 10 min at
8,000 3 g at 4 °C to generate pellet P8 and supernatant S8. S8 was
divided in two and either precipitated by the addition of trichloroacetic
acid to 10% or centrifuged at 100,000 3 g for 1 h to generate pellet P100.
For zymolyase treatment the cells were washed and resuspended at 50
A600 units/ml in zymolyase buffer (1.2 M sorbitol, 50 mM K2HPO4 pH 7.5,
40 mM 2-mercaptoethanol, 20 mM EDTA, 10 mM NaN3, 10 mM NaF)
containing zymolyase 20T. After a 40-min incubation at 30 °C, cells
were placed on a cushion of 1.5 M sorbitol, 50 mM K2HPO4, pH 7.5, 20
mM EDTA, 10 mM NaN3, 10 mM NaF and were centrifuged. For Western
blotting, all the samples were denatured during 5 min at 95 °C in
reducing sample buffer and run on a 6, 7.5, or 10% SDS-PAGE for
detection of antigens, respectively (32). Western blotting was carried
out with anti-Wbp1p, anti-alkaline phosphatase, anti-Gas1p, or anti-
Kex2p antisera or with affinity purified anti-Gpi7p or anti-Och1p an-
tibodies, always using the chemiluminescence ECL kit from Amersham
Pharmacia Biotech, Buckinghamshire, UK.
Labeling of Cells—Previously described procedures were used to
label cells with [2-3H]Man (23), [4,5-3H]DHS, or [2-3H]Ins (24) and to
label microsomes with UDP-[3H]GlcNAc (22). Delipidated protein ex-
tracts for SDS-PAGE and lipid extracts were made as described (24).
Lipid extracts were analyzed by ascending TLC using 0.2-mm thick
silica gel 60 plates with the solvent 1 (chloroform/methanol, 0.25% KCl
in water, 55:45:10, v/v) or solvent 2 (chloroform/methanol/water, 10:
10:3, v/v). Radioactivity was detected and quantitated by one- and
two-dimensional radioscanning (LB 2842; Berthold AG, Regensdorf,
Switzerland). TLC plates were sprayed with EN3HANCE and exposed
to film (X-Omat; Eastman Kodak Co.) at 280 °C.
Analytical Methods—Lipid extracts were deacylated with NaOH (34)
and treated with JBAM (35) as described. For GPI-PLD treatment lipid
extracts were dissolved in 20 mM Tris-HCl, pH 7.4, 0.1 mM CaCl2, 20%
1-propanol. Incubations were for 12 h at 37 °C. All treated lipid extracts
were desalted by partitioning between n-butyl alcohol and an aqueous
solution of 0.1 mM EDTA, 5 mM Tris-HCl, pH 7.5, and back extraction
of the butanol phase with water before TLC (23). Lipids were treated
with methanolic NH3 to remove the acyl group on Ins (36) and cleaved
using nitrous acid (37) as described. Lipids were purified by preparative
TLC on 0.2-mm thick Silica Gel 60 plates (Merck, Germany) in solvent
2. Radioactive spots were localized by radioscanning, scraped, and
eluted with solvent 2. A second run on TLC was done to obtain radio-
chemically pure M0, M4, and CP2.
Soluble head groups were obtained from lipids through GPI-PLD
treatment done as above, followed by limiting methanolic NH3 deacy-
lation (36). Non-hydrolyzed GPIs were removed by butanol extraction
(23). The water-soluble head groups were treated with JBAM (0.5 units)
or ASAM (5 microunits) as described (38). HF dephosphorylation was
FIG. 1. Presumed structure of the complete yeast precursor
glycolipid CP2. Relevant cleavage procedures are indicated. Man1,
Man2, Man3, and Man4 designate the a1,4-linked, a1,6-linked, and
a1,2-linked mannoses (Man). X indicates an HF-sensitive group that is
not yet defined chemically. R, alkyl; P, phosphate.
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done as described (39). The generated fragments were analyzed by
paper chromatography in methylethyl ketone/pyridine/H2O (20:12:11)
as described (39). Before paper chromatography the products were
N-acetylated and desalted over mixed-bed ion exchange resin AG-
501-X8 (Bio-Rad) unless indicated otherwise (34). Acetolysis was done
as described (40). Radiolabeled Manx-GlcNAc-[
3H]Ins (x 5 1, 2, 3, 4)
chromatography standards (Figs. 5 and 6, standards 1–4) were gener-
ated through fragmentation of [3H]Man-labeled head groups of CP2,
isolated from pmi40 by acetolysis then HF, HF then ASAM, JBAM then
HF, and HF treatments, respectively. The GlcNAc-[3H]Ins standard
(Figs. 5 and 6, standard 0) was generated by HF treatment of the
[3H]Ins-labeled head group of M0, obtained from sec53 cells. All stand-
ards were N-acetylated. Dionex HPLC analysis of non-dephosphoryl-
ated head groups was done exactly as described (23). Anchor peptides
were prepared from labeled proteins as described (23).
Limiting HF Treatment of Head Groups—For limiting HF treatment,
aliquots of radiolabeled head groups derived from CP2 and M4 and
prepared as above were dephosphorylated with 50 ml of 48% aqueous
HF at 0 °C as described (38) for 0–28 h. After neutralization with
saturated LiOH, samples were desalted by gel filtration through an
8-ml Sephadex G-10 (Amersham Pharmacia Biotech) column. Samples
were then dried in the Speed-Vac and treated with JBAM prior to
complete HF dephosphorylation (60 h, 0 °C). Samples were neutralized
again with LiOH and N-acetylated. Aliquots were dried and then di-
rectly applied to Whatman paper No. 1M and analyzed by descending
chromatography as described above.
RESULTS
Cloning of GPI7—As reported before (19) and shown in Fig.
2, wild type (wt) cells do not contain polar GPIs (lane 1), gpi8-1
accumulates CP2 as the most polar GPI lipid (lane 8), and
gpi7-1 and the gpi7-1/gpi8-1 double mutant accumulate M4
(lanes 4 and 6), thus demonstrating that gpi7-1 is epistatic to
gpi8-1 and suggesting that, during GPI biosynthesis, Gpi7p
may act before Gpi8p. Although the original gpi7 mutants and
the unrelated gpi8-1 mutant were not significantly tempera-
ture-sensitive (ts) for growth, the growth of the gpi7-1/gpi8-1
double mutant was strongly temperature-dependent. Transfec-
tion of a genomic library into this double mutant allowed the
isolation of clones containing complementing plasmids (19).
These clones were labeled with myo-[3H]inositol ([3H]Ins) at
37 °C, and the lipids were extracted and analyzed by TLC.
Upon transfection some gpi7-1/gpi8-1 indeed had regained the
ability to make CP2 (Fig. 2, lanes 6 and 7) and showed the same
lipid profile as gpi8-1 (Fig. 2, lane 8). All these clones harbored
plasmids containing YJL062w as the only complete ORF.
Transfection of a multicopy vector containing YJL062w under
its own promoter (pBF41, Fig. 3C) into gpi7-1 almost com-
pletely cured the accumulation of M4 (Fig. 2, lane 5). As ex-
pected, the accumulation of CP2 by gpi8-1 was not abolished by
the overexpression of YJL062w (Fig. 2, lanes 8 and 9).
YJL062w predicts an 830-amino acid membrane protein with
an N-terminal signal sequence for insertion into the ER, 5
potential N-glycosylation sites, and about 9–11 putative trans-
membrane domains (Fig. 3, A and B). YJL062w was deleted
and replaced by the selectable marker KanMX4. On rich me-
dium the deletants grew about as rapidly as wt cells at all
temperatures. Thus, YJL062w is not an essential gene. We
were unable to sporulate DYJL062/DYJL062 diploids indicat-
ing that YJL062 is required for sporulation. However,
DYJL062/YJL062 heterozygotes sporulated readily and
DYJL062 spores germinated normally. In accordance with pre-
vious results on gpi7 mutants (21), growth of DYJL062 (5
Dgpi7, see below) on plates at 37 °C was severely inhibited by
0.5 mg/ml Calcofluor White. DYJL062 accumulated M4 at even
higher levels than gpi7-1, and this accumulation was almost
completely suppressed by the transfection of pBF41 (Fig. 2,
lanes 2 and 3). Residual accumulation of M4 may be due to2 I. Flury, unpublished observations.
FIG. 2. Complementation of gpi7 mutants by YJL062w. Expo-
nentially growing cells were radiolabeled at 37 °C with [3H]Ins (2 mCi/
A600), and desalted lipid extracts were analyzed by TLC (solvent 2) and
fluorography. The same amount of radioactivity was spotted in each
lane. M(IP)2C, inositol phosphomannosylinositol phosphoceramide. The
upper part of the fluorogram was scanned at higher sensitivity to bring
into view the faint bands of M0. Lane 10 contains [3H]Ins. Samples still
contain residual amounts of free [3H]Ins after extraction into butanol.
The band migrating between CP2 and M4 in gpi8-1 is a GPI-PLD-, mild
base-, and JBAM-sensitive GPI intermediate containing the Man4-
GlcN-Ins core,2 but the structural differences between this species and
CP2 or M4 have not been identified.
FIG. 3. Sequence of GPI7. A, potential N-glycosylation sites are
shown in boldface. The predicted signal peptide is underlined. B shows
a hydrophobicity plot according to Kyte and Doolittle, in which the
hydrophobic sequences get a positive score. C shows the restriction map
of pBF41. The 3.6-kb insert (34–3604) contains GPI7 (5 YJL062w,
broad arrow). The EcoRV/BstYI fragment was expressed in bacteria to
get antigen for raising antibodies.
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some cells that lost the complementing plasmid. Transfection
of YJL062w under its own promoter on a single copy vector
(plasmid pBF43) was sufficient to suppress the accumulation of
M4 in a homozygous DYJL062/DYJL062 diploid (Fig. 2, lanes
11 and 12). As can be seen in Fig. 2, gpi7-1, DYJL062, DYJL062/
DYJL062, and gpi8-1 mutants also show minor amounts of the
GlcNa1,6(acyl3)Ins-P-DAG GPI intermediate M0, the accu-
mulation of which is believed to reflect a build up of GPI
intermediates throughout the biosynthetic pathway (Fig. 2,
lanes 2, 4, 6, 8, and 11). (It should be noted that some inter-
mediates of intermediate size are obscured on TLC by PI and
inositol phosphoceramide (41).) As expected, expression of
YJL062w abolishes the accumulation of M0 in gpi7-1 and
DYJL062 (Fig. 2, lanes 3, 5, and 12) but not in gpi7-1/gpi8-1
nor gpi8-1 (lanes 7 and 9), since in the latter the GPI biosyn-
thesis remains blocked. To evaluate if the mutation in gpi7-1 is
genetically linked to YJL062w, YJL062w was disrupted in a
heterozygous gpi7-1/GPI7 diploid. Correct replacement of one
YJL062w locus was verified by PCR in two independent gene-
ticin-resistant transformants. The verified deletants were
sporulated, and a total of 26 complete tetrads was labeled with
[3H]Ins to analyze the accumulation of M4. In all 26 tetrads
only two of the four segregants showed accumulation of M4,
whereas the other two showed the lipid profile of wt cells.
Geneticin resistance also segregated 2:2 and cosegregated with
M4 accumulation in all cases. This demonstrates that the mu-
tation of gpi7-1 is tightly linked to YJL062w which we hence-
forth call GPI7. Since a construct containing only 348 nucleo-
tides 59 of the initiation codon of GPI7 still retained significant
complementing activity, we also can dismiss the possibility
that the complementing activity of pBF41 is due to one of the
two small ORFs located on the opposite strand in the 59 up-
stream region of GPI7 and starting at 2409 and 2503 with
regard to the start codon of GPI7.
Characterization of the GPI Intermediate M4—We found
that M4, contrary to our initial expectation, contained an HF-
sensitive group on Man3 (Fig. 1). Indeed, treatment of the lipid
extracts of gpi7-1 with jack bean a-mannosidase (JBAM, an
exomannosidase) shifted M4 to a slightly less hydrophilic po-
sition on TLC (Fig. 4A, lanes 1 and 2) but not to the position of
M0. It seemed conceivable that JBAM did not remove more
than one Man from M4 because it was sterically hindered by
the detergent micelle in which M4 was embedded. To circum-
vent this problem, M4 was purified by preparative TLC, and its
hydrophilic head group was liberated by GPI-PLD, O-deacyl-
ated by NH3, and then subjected to several treatments as
indicated at the top of Fig. 5, A–D. The N-acetylated fragment
comigrated with the Man4-GlcNAc-Ins standard (Fig. 5A).
When treated with JBAM before HF, the resulting N-acety-
lated fragment comigrated with the Man3-GlcNAc-Ins stand-
ard, clearly indicating the presence of a blocking group on
Man3 (Fig. 5B). The blocking group on Man3 was HF-sensitive,
since JBAM done after HF produced a fragment comigrating
with GlcNAc-Ins (Fig. 5C). Aspergillus satoi a-mannosidase
(ASAM), a linkage-specific a1,2-exomannosidase, when used
after HF treatment, produced Man2-GlcNAc-Ins (Fig. 5D). The
migration of the fragments shown in Fig. 5, A and B, was much
slower when N-acetylation was omitted (not shown). This par-
tial characterization of M4 is consistent with the presence of a
classical Mana1,2(EtN-P3)Mana1,2Mana1,6Mana1,4-Glc-
Na1,6Ins core structure.
Having recently discovered an additional EtN-P on Man1 of
CP2 (22), we considered the possibility that M4 may be lacking
EtN-P on Man1. We thus proceeded to compare the non-de-
phosphorylated head groups of M4 and CP2 by Dionex HPLC
using a system in which the presence of negatively charged
phosphodiesters greatly retards the elution of oligosaccharides
(42). The non-dephosphorylated head groups of M4 and CP2
eluted as sharp peaks at fractions 22 and 31, respectively (not
shown). This wide separation suggested that the head group of
M4 contains less negative charge than the one of CP2. To assay
directly for a side chain on Man1 of M4, the head group of
[3H]Ins-labeled M4 was first cleaved by acetolysis, a procedure
which, under mild conditions, selectively cleaves a1,6-glyco-
sidic bonds (Fig. 1). Here this procedure is expected to produce
the labeled fragment (X-P3?)Mana1,4-GlcNa1,6-[3H]Ins with
X-P- being the substituent in question. The fragment was then
either treated with JBAM or control incubated and finally
dephosphorylated by HF, N-acetylated, and analyzed by paper
chromatography. As can be seen in Fig. 6, A and B, the (X-
P3?)Mana1,4GlcNa1,6Ins fragment of M4 is JBAM-resistant,
since successive treatment by acetolysis, JBAM, and then HF
generates Mana1,4GlcNa1,6Ins. The same had previously been
found for CP2 (22). Thus, the difference between the head
groups of M4 and CP2 cannot be explained by the presence or
absence of an HF-sensitive substituent on Man1: both lipids
have the same classical Man4-GlcN-Ins carbohydrate core stru-
cture, they both contain HF sensitive groups on Man1 and
Man3 (Fig. 1), but they migrate differently on TLC, and their
non-dephosphorylated head groups elute differently on Dionex
FIG. 4. Characterization of M4. A, gpi7-1 cells were preincubated
at 37 °C for 20 min and were labeled with [3H]Ins (2 mCi/A600). Lipid
extracts were treated (1) or control incubated (2) with either JBAM or
GPI-PLD or were deacylated by mild base treatment (NaOH). Desalted
products were analyzed by TLC (solvent 2) and fluorography. B, sec53
and Dgpi7 were preincubated and labeled with [3H]Ins at 37 °C (5
mCi/A600), and lipid extracts were treated with PI-specific phospho-
lipase C to get rid of labeled PI, and the GPI intermediates M0 and M4
were purified from sec53 and Dgpi7, respectively, by two rounds of
preparative TLC. Anchor peptides were prepared from [3H]Ins-labeled
W303 in the experiment described in Table I. M4 and anchor peptides
were treated with HNO2 to liberate the acyl-[
3H]Ins-P-lipid and
[3H]Ins-P-lipid moieties, respectively (Fig. 1). Samples were incubated
with (1) or without (2) methanolic NH3 to remove the acyl from the Ins,
desalted and separated by TLC (solvent 1), and processed for fluorog-
raphy. pG1, protein-derived glycerophospholipid 1; pC1 and pC2, pro-
tein-derived ceramides 1 and 2, see Sipos et al. (41). Other results of this
same experiment were described before (Ref. 41, therein Fig. 2).
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HPLC (data presented above and in Refs. 22 and 23). We thus
hypothesized that CP2 may contain either additional HF-
sensitive groups on GlcN, Man1, Man2, or Man3 or may con-
tain additional groups linked through the amino group of the
EtN-P on M1. Of these several theoretical possibilities, the only
ones that have been documented in other organisms are the
Man1-P group on the GlcN in Paramecium aurelia (43) and the
EtN-P group on Man2 in several mammalian GPI proteins, e.g.
human erythrocyte acetylcholinesterase (44), CD52-II (45), and
bovine liver 59-nucleotidase (46). We used limiting HF treat-
ment to test specifically if CP2 contains an HF-sensitive group
on Man2. If we assume that during HF treatment the EtN-Ps
are hydrolyzed in a random order, we may expect to find some
reaction intermediates lacking the HF-sensitive group on
Man3 while retaining EtN-P on Man2 or Man1. When such
intermediates subsequently are treated with JBAM and then
are dephosphorylated to completeness with HF, they should
yield Man2-GlcN-Ins and Man1-GlcN-Ins fragments, respect-
ively. For preliminary tests, CP2 head groups were first treated
with HF for 0.5, 1, 3, 9, 12, 18, or 28 h, then with JBAM, and
finally with HF for 60 h. These experiments showed that both
Man2-GlcN-Ins and Man1-GlcN-Ins fragments became visible
after 1 h of limiting HF treatment, peaked at 12 h, and rema-
ined detectable at all time points up to 28 h. In quantitative
terms it appeared that Man3-GlcN-Ins . Man2-GlcN-Ins $
Man1-GlcN-Ins at all time points. Importantly, treatment of
the head group of CP2 with HF for 12 h yielded substantial
amounts of Man2-GlcN-Ins and Man1-GlcN-Ins (Fig. 6C),
whereas the identical treatment performed with the head
group of M4 only yielded Man1-GlcN-Ins but no Man2-GlcN-Ins
(Fig. 6D). This result is compatible with the idea that Dgpi7
cells are unable to add an HF-sensitive group onto Man2 of the
GPI core (Fig. 1). It also confirms the presence of an HF-sensit-
ive group on Man1 of both M4 and CP2.
The Lipid Moieties of GPI Intermediates in Dgpi7 Are Nor-
mal—We looked for additional differences between M4 and
CP2 by analyzing the lipid moiety of M4. M4 is sensitive to
GPI-specific phospholipase D (GPI-PLD) and mild base treat-
ment (Fig. 4A, lanes 3–6), suggesting that its lipid moiety
consists of Ins-P-DAG. We previously reported that M4 is re-
sistant to PI-specific phospholipase C (21). This finding, to-
gether with the GPI-PLD sensitivity, can be taken as an indi-
cation for the presence of an acyl moiety attached to the Ins of
M4. We further released the (acyl3)Ins-P-DAG moiety of M4
with HNO2 as described recently (41). As shown in Fig. 4B, the
treatment of purified M4 by HNO2 produced a very hydropho-
bic species, which migrates very closely to M0, i.e. the
GlcN(acyl3)Ins-P-DAG accumulating in sec53 (Fig. 4B, lanes 7
and 9) (41). (As reported previously, the presence of GlcN on
these early precursors does not significantly influence their
migration in TLC, for discussion see Sipos et al. (41).) Partial
deacylation of the M4-derived lipid moiety by NH3 produced PI
and lyso-PI (Fig. 4B, lane 10). This PI was compared with pG1,
the PI species obtained by HNO2 treatment of protein-bound
GPI anchors from the corresponding wt strain (Fig. 4B, lane
11). The comparison shows that M4 contains a PI moiety that
migrates clearly less than pG1, whereas a lyso-PI of M4 mi-
grates slightly more than the lyso-PI species generated by
methanolic NH3 treatment of anchor peptides (Fig. 4B, lanes 10
and 12). Very similar results had been obtained previously
when comparing protein-derived PI moieties with the PI moi-
eties of M0 from sec53 and of CP2 from gpi8-1 (41). In addition
we isolated from Dgpi7 the recently identified GPI intermedi-
ates that are obscured in TLC by PI and inositol phosphocer-
amides (Ref. 41, therein Fig. 6A), and we found that they are
exactly the same as the corresponding intermediates from wt
cells by all criteria (not shown). Thus, it seems that M4 and
other GPI intermediates of Dgpi7 contain the same PI moiety
as early and late GPI intermediates accumulating in other
mutants or in wt cells, and we therefore conclude that the
difference between CP2 and M4 is solely due the difference in
their head groups.
Lack of Gpi7p Affects the in Vitro Biosynthesis of GPI Pre-
cursor Lipids—When yeast microsomes are incubated in the
presence of UDP-[3H]GlcNAc, ATP, coenzyme A, GDP-Man,
and tunicamycin, they generate labeled GPI intermediates as
the only kind of labeled lipids (22, 47). Wild type microsomes
make GPI intermediates up to CP2. Although a large array of
incomplete intermediates is also generated, the pattern of la-
beled intermediates is fairly reproducible. When we used Dgpi7
FIG. 5. Analysis of the head group of M4 using HF, JBAM, and
ASAM. Dgpi7 was labeled with [3H]Ins at 37 °C; M4 was purified and
used to prepare head groups. Head groups were subjected to HF and
N-acetylation (A); JBAM, then HF, then N-acetylation (B); HF, then
N-acetylation, then desalting, then JBAM (C); HF, then N-acetylation,
then desalting, then ASAM (D). The thus generated fragments were
separated by paper chromatography, and radioactivity contained in
1-cm wide strips was determined through scintillation counting. The
position of standards run in parallel on the same paper are indicated:
2–4, Manx-GlcNAc-Ins with x 5 2, 3, or 4. 0, GlcNAc-Ins.
FIG. 6. M4 of Dgpi7 contains an HF-sensitive substituent on
Man1 but lacks an HF-sensitive substituent on Man2. CP2 and
M4 head groups were obtained from [3H]Man labeled pmi40 and
[3H]Ins labeled Dgpi7, respectively. A and B, head groups of M4 were
subjected to acetolysis and then either treated with JBAM (B) or left
untreated (A). Finally all products were dephosphorylated with HF,
N-acetylated, and analyzed by paper chromatography. C and D, head
groups were treated for 12 h with HF, desalted, treated with JBAM,
treated with HF for 60 h, N-acetylated, and finally analyzed by paper
chromatography. Standards 0–4 are Manx-GlcNAc-Ins (x 5 0, 1, 2, 3, 4).
Free [3H]Man ran out of the paper shown in C.
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microsomes, they reproducibly made all the normal intermedi-
ates down to a band comigrating with M4 of [3H]Ins-labeled
Dgpi7 cells, but they consistently failed to make CP2 (Fig. 7).
When the labeled lipid extract was treated with JBAM, most of
the band comigrating with M4 was shifted to a less hydrophilic
position, much in the same way as seen for [3H]Ins-labeled M4
(Fig. 2, lanes 1 and 2). Thus, the M4 accumulation of Dgpi7 can
be reproduced in vitro. This result implies that the Gpi7p
present in wt microsomes is functional in vitro.
Characterization of Gpi7p—Gpi7p was characterized using
affinity purified rabbit antibody made against the N-terminal,
hydrophilic part of GPI7 (Fig. 3B). As shown in Fig. 8A, the
antibody recognized a heterogeneously glycosylated 208-kDa
protein, the estimated molecular mass of various glycoforms
ranging, after heavy exposure, from about 130 to 230 kDa (Fig.
8A, lane 2). The predicted mass of the protein before and after
removal of the signal sequence is 94,832 and 92,207 Da, respec-
tively. In glycosylation mutants Doch1/mnn1 or mnn9 which
are totally or partially deficient in the elongation of N-glycans
in the Golgi, Gpi7p has an estimated mass of 108 and 115 kDa,
respectively (Fig. 8A, lanes 1 and 7). pmi40 has a ts deficiency
in Man biosynthesis that is partial at 24 °C (48). In pmi40
grown at 24 °C the average mass of Gpi7p is around 150 kDa
(Fig. 8A, lane 6). (This suggests that full elongation of N-
glycans is not necessary for Gpi7p function since, when shifted
from 24 to 37 °C, pmi40 cells are able to make CP2 (23).)
Tunicamycin treatment of wt or pmi40 cells resulted in the
appearance of a single, relatively sharp band of an apparent
molecular mass of about 83 kDa (Fig. 8A, lanes 3 and 5). The
protein could also be deglycosylated to an apparent molecular
mass of 86 kDa by treatment with endoglycosidase H (not
shown). All these data concurrently indicate that Gpi7p con-
tains several N-glycans that are heavily elongated in the Golgi
but contains no or only few O-glycans. In the cell lysate Gpi7p
was rapidly degraded by an endogenous protease which, how-
ever, could be inhibited by 10 mM EDTA. Gpi7p is associated
with membranes since it could be sedimented by ultracentrif-
ugation of lysates at 100,000 3 g for 60 min (Fig. 8B, lanes 1
and 2). Gpi7p was neither dissociated from membranes by
NaCl nor sodium carbonate at pH 11, nor urea, but it was
efficiently solubilized by Triton X-100 or SDS (Fig. 8B). The
presence of an N-terminal signal sequence and the large
amount of N-glycans suggested that the hydrophilic N-termi-
nal part of the protein, which contains 3 of the 5 potential
N-glycosylation sites, would reside on the lumenal or ectocyto-
plasmic side of the membrane. We tried to confirm this orien-
tation by protease protection assays on microsomes. As shown
in Fig. 8C, neither Gpi7p nor Wbp1p, which was used as a
control, were degraded by proteinase K unless microsomes
were permeabilized with Triton X-100. Wbp1p has been dem-
onstrated to be a lumenal ER protein (49), and our result thus
shows that the N-terminal hydrophilic part of Gpi7p is not
accessible to protease in these microsomes. It is noteworthy
that proteinase K did not reduce the molecular mass of Gpi7p,
thus indicating that the cytosolic loops between the predicted
transmembrane domains of the C-terminal part of Gpi7p are
not accessible to proteinase K in native microsomes.
The cellular localization of Gpi7p was investigated by sub-
cellular fractionation as shown in Fig. 8D. Differential centrif-
ugation at 8,000 and 100,000 3 g for 10 and 60 min, respec-
tively, achieved satisfactory separation of the Golgi markers
Kex2p and Och1p from the ER marker Wbp1p and from the
vacuolar alkaline phosphatase. We were concerned that the
relative amounts of these proteins in the 100,000 3 g pellet
FIG. 7. Microsomes of Dgpi7 synthesize M4 and not CP2. Micro-
somes of W303 wild type or Dgpi7 were incubated with 6 mCi of UDP-
[3H]GlcNAc, GDP-Man, tunicamycin, and ATP for 1 h at 37 °C as
described (22). The glycolipid products were extracted and then run on
TLC with solvent 2. The extract in lane 3 was first treated with JBAM.
On the basis of the preceding analysis the band denoted with an
asterisk can be presumed to be an M4 derivative in which Man4 has
been removed.
FIG. 8. Membrane association, orientation, and localization of
Gpi7p. A, exponentially growing cells were broken with glass beads in
TEPI buffer as described (19); lysates were centrifuged at 10,000 3 g for
15 min at 4 °C, and microsomal pellets were processed for SDS-PAGE.
Cells in lanes 3 and 5 had been grown in 20 mg/ml tunicamycin (Tm) for
90 min. B–D, exponentially growing W303 cells were broken with glass
beads using the buffers indicated under “Experimental Procedures,”
and cell wall debris was removed by centrifugation at 600 3 g. B,
aliquots of cell lysate were incubated for 30 min at 0 °C with 0.5 M NaCl,
0.8 M urea, 1% Triton X-100 (TX-100), 0.1 M Na2CO3, pH 11, or 1% SDS.
Subsequently membranes were sedimented by ultracentrifugation to
get supernatant (S) and pellet (P) fractions. C, cell lysate was sedi-
mented at 13,000 3 g for 15 min, and the membrane pellet was thor-
oughly resuspended and digested with 10 or 25 mg/ml proteinase K (prot
K) at 0 °C for 20 min in the presence or absence of 0.5% Triton X-100.
D, cell lysates were subjected to differential centrifugations at 8,000
and 100,000 3 g. These centrifugations generated pellet P8 containing
ER, PM, and vacuolar membranes and pellet P100 which contains Golgi
membranes. The 8,000 3 g supernatant was also precipitated with
trichloroacetic acid (TCA). In all panels the lanes contain material
derived from 1 A600 of cells except for lanes 1 and 7 of A which contain
0.3 A600.
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may be underestimated due to ongoing proteolytic degradation
during the 100,000 3 g spin. Therefore the supernatant of the
8,000 3 g spin was split whereby proteins were immediately
precipitated with trichloroacetic acid in one half, and the other
half was pelleted at 100,000 3 g. Gpi7p was exclusively found
in the 8,000 3 g pellet (P8) and thus is associated with either
the ER, the vacuole, or the PM but not with the Golgi. As shown
in Fig. 9A low amounts of proteinase K added to intact cells
hydrolyzed all of the mature Gpi7p. In contrast, Wbp1p and the
105-kDa ER form of Gas1p were completely resistant to this
treatment unless membranes were permeabilized with Triton
X-100 (Fig. 9A, lane 6). The mature 125-kDa form of Gas1p was
found to be partially resistant to proteinase K, indicating either
a tighter interaction of Gas1p with some cell wall components
or the existence of an internal pool of Gas1p as proposed earlier
(50). Crude zymolyase treatment of intact cells also removed all
of the mature form of Gpi7p (Fig. 9B), whereas recombinant
zymolyase left Gpi7p intact (not shown). Longer exposures
showed the presence of several minor bands of smaller size all
of which were also present in Dgpi7 cells except for a 108-kDa
form of Gpi7p (Fig. 9C, lanes 7 and 8). This material seems to
be an ER form in transit to the surface since it was no more
detectable if cells were preincubated with either cycloheximide
or tunicamycin (Fig. 9C, lanes 1–6). These data also indicate
that mature Gpi7p is relatively rapidly degraded or becomes
resistant to extraction with SDS. Globally these data indicate
that the bulk of Gpi7p is exposed at the cell surface but that a
small amount of core-glycosylated material is found in the ER
in transit to the cell surface. For the moment it is unclear why
Gpi7p was completely protected in microsomes, since it has
been claimed that PM does not form closed vesicles upon ho-
mogenization (51). It is conceivable that Gpi7p resides in spe-
cial PM subdomains that form closed vesicles upon homogeni-
zation or that centrifugation of microsomes generated protease-
resistant membrane aggregates (51).
Deletion of GPI7 Alters GPI Protein Transport and Remod-
eling—We previously reported on the accumulation of the im-
mature 105-kDa ER form of Gas1p in gpi7 mutants (21). We
therefore investigated GPI protein transport in Dgpi7. Indeed,
by pulse-chase experiments we found that the maturation of
GPI proteins Sag1p and Gas1p was slowed 2–3-fold as com-
pared with wt cells, whereas the maturation of carboxypepti-
dase Y proceeded with normal kinetics (not shown). This indi-
cates that the transport of GPI proteins in Dgpi7 is specifically
retarded. Nevertheless, in rich media Dgpi7 cells grow at
roughly the same rate as wt cells. They also incorporate [3H]Ins
with the same efficiency as wt cells.
The lipid remodeling of GPI anchors is significantly altered
in Dgpi7. As seen in Table I, the proportion of ceramides (pC1
and pC2) in anchor peptides from Dgpi7 is drastically de-
creased, whereas the fraction of DAG-containing lipids ((pG1)
is correspondingly increased. It should be noted that at the
time of analysis, i.e. 75 min after addition of [3H]Ins, the
relative amounts of mild base-sensitive and mild base-resistant
anchors are no longer changing and represent the steady state
proportion of these two anchor types (41, 52). It is important to
realize that pG1 also represents a remodeled form of the anchor
lipid in which a long chain fatty acid has replaced the original
fatty acid present in sn-2 of the glycerol of the CP (Fig. 1). It
thus appears that the relative decrease of ceramide remodeling
goes along with a compensatory increase in DAG remodeling. A
relative reduction in ceramide remodeling was also observed
when we compared the efficiency of [3H]Ins and [3H]dihy-
drosphingosine ([3H]DHS) incorporation into GPI proteins. As
can be seen in Fig. 10, the ratio of [3H]DHS/[3H]Ins incorpora-
tion into proteins is much higher in wt than in Dgpi7 (Fig. 10,
lanes 1–4). The lack of incorporation of [3H]DHS in Dgpi7
cannot be explained by an increase of the endogenous produc-
tion of DHS in Dgpi7, since the difference between wt and
Dgpi7 persists, even when all endogenous DHS biosynthesis is
blocked by myriocin (Fig. 10, lanes 5 and 6). The defect in
FIG. 9. Gpi7p is localized at the cell surface. Cells in the early
exponential phase growing at 30 °C in YPD were used. A, intact W303
cells were treated with cysteamine chloride and then treated with the
indicated concentrations of proteinase K (prot K) exactly as described
(65) except that the EDTA concentration was raised to 20 mM. In lane
6, Triton X-100 was added to 1%. B, W303 cells were treated with
zymolyase 20T at the indicated concentrations. C, W303 or Dgpi7 cells
were either lysed directly or after having been incubated for 30 or 60
min at 10 A600/ml in the presence of cycloheximide (200 mg/ml) or
tunicamycin (Tm, 20 mg/ml). Cells were lysed by boiling in sample
buffer and processed for SDS-PAGE and Western blotting with anti-
bodies against Gpi7p, Gas1p, or Wbp1p.
TABLE I
Quantitation of GPI anchor lipids
Cells were labeled with [3H]Ins (5 mCi/A600) for 75 min at 37 °C.
Incorporation of [3H]Ins into lipids ranged from 43 to 49% of the radio-
activity added to cells. Proteins were extensively delipidated, and an-
chor peptides were prepared as described (41). Anchor peptides were
treated with HNO2 to liberate the [
3H]Ins-P-lipid moieties; the products
were desalted by partitioning between butanol and water, and the
labeled lipid products were separated by TLC and quantitated by ra-
dioscanning. Results of the quantitation of anchor lipids pG1, pC1, and
pC2 are given as percentage of the total radioactivity of anchor pep-
tides. The remaining 7–11% that are not accounted for stayed at the
origin and represent residual anchor peptides that had not been cleaved
by HNO2 treatment. An aliquot of W303 anchor lipids is shown in Fig.
4B, lane 11.
pG1 pC1 pC2
W303 22.2 63.6 7.4
X2180 24.2 61.2 4.8
gpi8–1 23.8 63.9 2.6
Dgpi7 68.8 19.3 1.1
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remodeling seems to be affecting mostly the maturation pro-
cesses in the Golgi and/or PM (Golgi/PM remodeling) since, as
shown in Fig. 10, lanes 7–10, the ratio of [3H]DHS/[3H]Ins
incorporation into proteins in the Dgpi7/sec18 double mutant
was the same as in sec18. Also, when using stringent conditions
under which one observes only ER or only Golgi/PM remodelase
(24), remodeling in the ER appeared relatively normal,
whereas remodeling in the Golgi/PM was reduced (Fig. 10,
lanes 11–14, 119, and 129). The relatively low amount of pC2 in
anchor lipids of Dgpi7 (Table I) may be a consequence of this
relative deficiency of Golgi/PM remodeling, since pC2 type an-
chors are only generated by the Golgi/PM but not the ER
remodelase (24, 41). The relationship between the specific re-
tardation of GPI protein transport, reduced Golgi/PM remod-
eling, and increased remodeling toward pG1 is for the moment
unclear.
DISCUSSION
Yeast and mammals contain the same GPI carbohydrate core
structure. This suggests that the GPI anchoring pathway has
been established early in evolution and has rigorously been
conserved in widely diverging organisms. On the other hand,
the side chains added to this core as well as the lipid moieties
of the anchor tend to vary a lot between different species (1).
The GPI anchors of S. cerevisiae contain two types of side
chains as follows: one or two mannoses are linked to Man3 (53)
and an EtN-P side chain is linked to Man1.3 Both side chains
are already present on the precursor lipid CP2 (22, 23). These
two side chains are also found in some vertebrates, including
mammals, and possibly in Dictyostelium discoideum (1), sug-
gesting that not only the GPI core structure but also certain
kinds of side chains have been invented in and conserved since
early times of evolution. Here we present evidence for yet a
further, possibly conserved HF-sensitive substituent on CP2
which is attached to Man2. So far, the only side chain attached
to Man2 reported in the literature is EtN-P. EtN-P was found
by mass spectrometry on 15% of anchors of human erythrocyte
cholinesterase and 3% of bovine liver 59-nucleotidase (44, 46).
Partial acid hydrolysis has also indicated an HF-sensitive sub-
stituent on Man2 in 40% of CD52-II (45). Analysis of the eth-
anolamine/Ins ratio in GPI anchors of porcine renal membrane
dipeptidase and of human placental alkaline phosphatase
yielded values of 2.5 and 2.4, suggesting the presence of EtN-P
on Man2 in 50 and 40% of their anchors, respectively (54, 55).
However, no such side chain was detected in other mammalian
GPI proteins such as rat brain Thy-1 glycoprotein (56) or ham-
ster scrapie prion (57). It may be that in many studies part or
all of EtN-P side chains on Man2 and Man1 were hydrolyzed by
an unspecific phosphodiesterase during the purification of the
respective GPI proteins and preparation of anchor peptides
using Pronase. Such a phosphodiesterase activity may explain
why we failed to detect any EtN-P side chain on GPI-anchored
yeast proteins in the past (53), although we now have firm
evidence for the presence of an HF-sensitive substituent on
Man1.3 The chemical nature of the side chain on Man2 of CP2
remains to be determined. The presence of an HF-sensitive side
chain on Man2 of CP2 has its parallel in human cells. Indeed,
there is evidence for an HF-sensitive group on Man2 of H8, the
most polar GPI lipid of HeLa cells (58). The EtN-P side chains
on Man1 and Man3 being conserved between mammalian or-
ganisms and yeast, it appears reasonable to speculate at this
point that the analogy between mammalian and yeast anchors
may extend to the substituent on Man2, i.e. that also the side
chain on Man2 of yeast GPI structures may consist of an EtN-P
and that this EtN-P may be present on some mature GPI
proteins of S. cerevisiae.
Dgpi7 cells are hypersensitive to Calcofluor White and hence
have some difficulty in constructing their cell walls. Several
reasons can be envisaged. (i) The side chain on Man2 may be
important for the interaction of CPs with the transamidase
complex and for their efficient transfer onto proteins. Recent
data show that a small reduction of Gpi8p renders transami-
dase activity rate-limiting.3 The synthetic effect of gpi7 muta-
tions with gpi8 mutations suggests that deletion of GPI7 may
have a similar effect. A decreased transamidase activity may
particularly affect the anchoring of certain GPI proteins that
have a low affinity for the transamidase even though the global
rate of GPI biosynthesis and [3H]Ins incorporation into pro-
teins of Dgpi7 is not grossly reduced. Thus it is conceivable that
some GPI proteins important for cell wall architecture are
lacking in Dgpi7. (ii) The side chain on Man2 may serve as an
attachment point for the covalent linkage of b1,6-glucans to the
anchor moiety of cell wall proteins although a recent analysis of
the linkage region between the GPI anchor remnant and b1,6-
glucans rather showed a direct glycosidic linkage between
Man1 and the b1,6-glucan (6). (iii) The side chain may serve as
a recognition signal for enzymes or proteins that facilitate the
packaging of GPI proteins into vesicles, for remodelases that
3 I. Imhof, U. Meyer, A. Benachour, I. Flury, E. Canivenc-Gansel, C.
Vionnet, and A. Conzelmann, manuscript in preparation.
FIG. 10. Ceramide remodeling of GPI anchors is reduced in Dgpi7. Cells growing exponentially in SDCUA were used. Cells were labeled
by the addition of either 25 mCi of [3H]DHS (D) or [3H]Ins (I) to an aliquot of 2.5 A600 of cells exactly as described (24). Lanes 1–6, precultures and
labelings were at 30 °C. Cells were preincubated with (1) or without (2) 40 mg/ml of myriocin (myr) for 20 min before addition of the radiotracers.
Lanes 7–10, sec18 or sec18 Dgpi7 double mutants were precultured at 24 °C and preincubated for 10 min at 37 °C before addition of the tracers.
Lanes 11–14, cells were labeled in the presence of cycloheximide under conditions in which only the Golgi/PM remodelase (lanes 11 and 12) or only
the ER remodelase (lanes 13 and 14) is probed (Ref. 24, therein Fig. 7 (Golgi/PM remodelase) and Fig. 8 (ER remodelase)). All samples were
processed for SDS-PAGE under reducing conditions and fluorography. Lanes 119 and 129 were scanned at an increased sensitivity.
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exchange their lipid moieties, or for hydrolases or transglyco-
sidases that remove parts of the GPI anchor of cell wall pro-
teins and hook the GPI remnant onto b1,6-glucans (4, 5).
Our data further show that ceramide remodeling in the
Golgi/PM is significantly reduced in Dgpi7, whereas remodeling
toward pG1 is increased whereby it is not clear if pG1 remod-
eling is increased because ceramide remodeling is decreased or
if ceramide remodeling is decreased because pG1 remodeling is
increased. Moreover, the relationship of the alteration of GPI
remodeling with the other phenotypic changes of Dgpi7can be
explained in several ways. (i) Previous studies showed that
remodeling toward pG1 occurs in the ER and that retention of
GPI proteins in the ER in secretion mutants maintains a high
pG1/pC1 ratio on these proteins (41). Thus, if the substituent
on Man2 of GPI anchors is important for efficient packaging of
GPI proteins into transport vesicles, the delay in export of GPI
proteins out of the ER may give the ER remodelase generating
pG1 prolonged access to the GPI proteins and may thus cause
a relative increase of pG1. (ii) The side chain on Man2 may
serve as a recognition signal for Golgi/PM remodelase. (iii) We
also considered the possibility that Gpi7p itself may be a
Golgi/PM remodelase. This latter hypothesis would not directly
explain why Dgpi7 cells cannot attach the HF-sensitive substit-
uent onto Man2 and would imply that the addition of this side
chain somehow is directed by the prior attachment of a ceram-
ide moiety. This, however, is clearly not the case, since CP2 also
contains the HF-sensitive side chain on Man2, although its
lipid moiety consists of DAG (23). Thus we believe that the
reduced Golgi/PM remodeling of GPI proteins in Dgpi7 is sec-
ondary to the lack of a substituent on Man2.
Our previous data suggested that CP2 can be transferred to
proteins (23), and our working hypothesis until recently as-
sumed that CP2 represents the GPI lipid used for GPI anchor-
ing also by normal cells that do not accumulate this lipid (“CP2
hypothesis”). By consequence we would have predicted that all
the enzymes required for the elaboration of CP2 are localized in
the ER. Paradoxically, the subcellular fractionation experi-
ments and protease treatment of intact spheroplasts strongly
suggest that the bulk of Gpi7p resides at the cell surface (Fig.
9, A and B). Moreover, although we recently succeeded in
demonstrating the presence of an HF-sensitive group on Man1
of immature ER forms of GPI proteins, we presently lack the
tools to look for such a group on Man2. Thus, the so far avail-
able data raise a doubt whether it is CP2 which is added to GPI
proteins in the ER, and we therefore are presently considering
the possibility that other GPI lipids than CP2 are the physio-
logical substrate of the ER transamidase. In fact, neither CP2
nor M4 can be detected in wt cells. It therefore seems possible
that under physiological conditions cells add M4 to GPI pro-
teins (“M4 hypothesis”) and that CP2 is elaborated only in
mutants in which M4 cannot be transferred to proteins, spills
out of the ER, and reaches the PM. It is noteworthy that Dgpi7
incorporates [3H]Ins at a normal rate into proteins suggesting
that the transamidase is perfectly able to transfer M4. Thus,
the side chain on Man2 may normally not be added to GPI
proteins or only be added after GPI proteins arrive at the cell
surface. The M4 hypothesis, however, does not explain why M0
and M4 accumulate in Dgpi7, whereas M0, M4, and CP2 re-
main undetectable in wt cells (Fig. 2, lanes 1 and 2) or why
gpi8-1, deficient in the transfer of GPIs onto proteins, accumu-
lates CP2 (19, 21). It also fails to explain the delayed matura-
tion of GPI proteins and the reduced rate of GPI remodeling
observed in Dgpi7. To save the M4 hypothesis, the accumula-
tion of GPI intermediates in Dgpi7 could be rationalized by
assuming that the substituent on Man2 serves to mark super-
numerary GPIs for degradation, but also this assumption does
not explain the observed accumulation of CP2 in gpi8. Thus,
although our results raised the possibility that M4 is the phys-
iological GPI lipid for GPI anchoring, this M4 hypothesis leaves
many results unexplained and the data are more easily ex-
plained by our original CP2 hypothesis. For one, the synchro-
nous accumulation of M4 and CP2 in all our gpi8 mutants
argues that M4 is not a better substrate for the transamidase
than CP2. CP2 may physiologically be produced by the small
amount of Gpi7p in the ER (Fig. 9C). Alternatively, it is con-
ceivable that M4 is transported from the ER to the PM, is
converted there to CP2, and is then transported back to the ER
by some not yet elucidated mechanism. In this context it is
noteworthy that the biosynthesis of GPIs by wt microsomes in
vitro produces CP2 in good yield, i.e. the in vitro system adds
the substituent on Man2. This in vitro system does not contain
cytosol nor GTP and hence should not support vesicular trans-
port from ER- to Golgi-derived microsomes (59). It is possible,
however, that GPI lipids are transported between microsomes
or membrane fragments by means of lipid transfer proteins or
through direct contact between membranes. It also can be
envisaged that juxtaposition of membranes allows enzymes
present in one membrane to work on lipids in another mem-
brane. The same mechanisms may also operate in intact cells.
Clearly the identity of the physiological GPI lipid substrate of
the transamidase will have to be established by further
experiments.
Homology searches show that two ORFs of S. cerevisiae are
related to GPI7, MCD4 (5 YKL165c), and YLL031c. They be-
long to a novel gene family comprising for the moment the nine
members shown in Table II which, based on the many predicted
transmembrane domains, were previously classified as puta-
tive permeases (60). Pairwise alignment allows us to group
TABLE II
GPI7 has homologues in other species
Homologous sequences were compared by ClustalW at the European Bioinformatics Institute (www2.ebi.ac.uk/clustalw/). The aligned scores for
pairwise alignments are reported; a high score indicates high homology. ORFs that have not received gene names are indicated by their
chromosomal denominator (S. cerevisiae) or the NCBI protein identification number (PID). Subfamilies are separated by blank lines. Alignments
within a given subfamily are in bold. S.c., S. cerevisiae; S.p., Schizosaccharomyces pombe.
1 2 3 4 5 6 7 8 9
1 YJL062w 5 GPI7, S.c.
2 YA93, (1175452), S.p. 29
3 (1132507), C. elegans 22 26
4 YLL031c, S.c. 22 19 16
5 (2984587) homo sapiens 18 20 16 24
6 (2257562) S.p. 20 20 18 28 23
7 (2734088) C. elegans 19 19 16 21 20 23
8 MCD4, YKL165c S.c. 15 15 18 12 12 14 12
9 (2879870) S.p. 16 14 14 12 11 13 1 39
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them into three subfamilies of more closely related ORFs. All
nine ORFs predict membrane proteins of about 100 kDa having
an N-terminal signal sequence, a hydrophilic N-terminal part,
and multiple transmembrane domains in their C-terminal half.
mcd4 mutants were obtained in a screen for cells deficient in
the cell cycle controlled polarization of growth, a phenotype
also generated by mutations in the exocyst or in N-glycosyla-
tion (61). The subfamilies typified by GPI7 and YLL031c are
more closely related to each other than to the MCD4 subfamily.
All nine family members contain two conserved motifs at about
the same position in the hydrophilic N-terminal domain,
namely HXLGXDXXGH and DHGMXXXGXHG. These motifs
are also found in two EST clones from human cDNA that have
high homology to MCD4 (NCBI PID 1779747 and 1765215,
ClustalW alignments giving aligned scores of 46 and 35). Very
interestingly, by a reiterated Psi Blast search at the National
Center of Biotechnology Information (NCBI) (62) one can find a
highly significant homology of all three subfamilies with a
large family of phosphodiesterases. The large majority of these
homologous sequences encode mammalian cell-surface proteins
classified as alkaline phosphodiesterase I, nucleotide pyrophos-
phatase, or alkaline phosphatase. The homology comprises a
region of about 220–240 amino acids in the N-terminal hydro-
philic part of GPI7, YLL031c, and MDC4. The homology of
GPI7 in this region with mammalian and plant phosphodies-
terases amounts to 17–18% identity and 30–34% similarity
and comprises a motif PTXTX8TGX2P which is common to
bacterial, viral, plant, and mammalian phosphodiesterases.
This homology may suggest that Gpi7p itself is the transferase
adding the phosphodiester-linked substituent on Man2. In this
context it is interesting to note that the EtN-P on Man3 of the
GPI anchor has been shown to be transferred by transesterifi-
cation using phosphatidylethanolamine as donor of EtN-P (63,
64). Mutants in YLL031c also accumulate abnormal GPI inter-
mediates which on TLC have about the same mobility as M4
suggesting that YLL031c is similarly involved in adding
EtN-P.2 Thus, it is conceivable that not only the GPI7 subfam-
ily but also other subfamilies are involved in the transfer of
EtN-P onto the GPI core structure. However, the transesteri-
fication activity of Gpi7p will have to be shown directly before
one can exclude that the primary function of Gpi7p is to gen-
erate some signal from the cell wall which regulates GPI pro-
tein transport and remodeling as well as side chain addition to
GPI structures.
It is interesting that subfamily members belonging to differ-
ent species are more closely related to each other than family
members belonging to a single species. This can be seen when
comparing the pairwise alignment scores among the three
ORFs of S. cerevisiae or the three ORFs of Schizosaccharomyces
pombe with the scores among subfamily members (Table II). In
evolutionary terms this suggests that the divergence of these
three subfamilies occurred earlier than the separation of the
lineages leading to S. cerevisiae, S. pombe, and Caenorhabditis
elegans. This implies that the HF-sensitive group on Man2 is of
very ancient origin. GPI7 bears no resemblance with PIG-F, a
mammalian gene encoding for a highly hydrophobic membrane
protein involved in the addition of EtN-P to Man3 (10). The
exact role of PIG-F has not yet been elucidated.
It will be interesting to find the human homologues of GPI7.
It may be that this gene, as in S. cerevisiae, plays a more
dispensable role in GPI anchoring than the enzymes involved
in the elaboration of the carbohydrate core structure such as for
instance PIG-A/GPI3/CWH6/SPT14 (7). Thus, although defi-
ciencies in PIG-A are only acquired by somatic cells, deficien-
cies in the human GPI7 homologue may be transmittable
through the germ line as well.
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